Seoulin Bioscience Co.Ltd (038070) — Cash Flow Reinvestment Rate
Seoulin Bioscience Co.Ltd (038070) has a Cash Flow Reinvestment Rate of 3.24x as of December 2025, reinvesting ₩2.05 Billion (capex ₩10.90 Million plus investments ₩-2.04 Billion) from operating cash flow of ₩631.76 Million. Check how high is Seoulin Bioscience Co.Ltd's earnings quality to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Seoulin Bioscience Co.Ltd Cash Flow Reinvestment Rate (2013–2025)
Historical reinvestment intensity for Seoulin Bioscience Co.Ltd across 11 annual periods. Explore Seoulin Bioscience Co.Ltd long-term investment intensity to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Seoulin Bioscience Co.Ltd (2013–2025)
Year-by-year capital reinvestment analysis for Seoulin Bioscience Co.Ltd. For live market cap and broader valuation context, see Seoulin Bioscience Co.Ltd stock valuation.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 3.53x | ₩16.79 Billion | ₩4.76 Billion | ₩507.47 Million | ▼ -88.5% |
| 2023 | 30.63x | ₩28.50 Billion | ₩930.57 Million | ₩974.21 Million | ▲ +723.4% |
| 2021 | 3.72x | ₩33.17 Billion | ₩8.92 Billion | ₩1.67 Billion | ▲ +582.2% |
| 2020 | 0.55x | ₩2.01 Billion | ₩3.68 Billion | ₩401.34 Million | ▲ +60.2% |
| 2019 | 0.34x | ₩2.49 Billion | ₩7.32 Billion | ₩269.29 Million | ▼ -22.9% |
| 2018 | 0.44x | ₩1.84 Billion | ₩4.17 Billion | ₩408.02 Million | ▼ -95.6% |
| 2017 | 10.01x | ₩13.03 Billion | ₩1.30 Billion | ₩8.73 Billion | ▲ +84.0% |
| 2016 | 5.44x | ₩15.00 Billion | ₩2.76 Billion | ₩7.21 Billion | ▲ +401.9% |
| 2015 | 1.08x | ₩4.46 Billion | ₩4.12 Billion | ₩3.74 Billion | ▲ +195.0% |
| 2014 | 0.37x | ₩1.01 Billion | ₩2.74 Billion | ₩761.57 Million | ▲ +3162.2% |
| 2013 | 0.01x | ₩55.65 Million | ₩4.94 Billion | ₩55.65 Million | — |